Monday, October 5, 2026

AI Memory Boom Lifts Micron and SanDisk to 2026's Front Ranks, But Both Retreat From June Peaks

Micron and SanDisk are among 2026's top-performing chip stocks on AI memory demand, but both have fallen sharply from June record highs. Figures dated and sourced.

LM Salvado

August 12, 2026

AI Memory Boom Lifts Micron and SanDisk to 2026's Front Ranks, But Both Retreat From June Peaks
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Micron and SanDisk have ranked among 2026's best-performing chip stocks, powered by AI data-center demand for high-bandwidth memory and enterprise flash storage — though both have retreated from all-time highs reached in June.

As of early August 2026, SanDisk was up roughly 574% year-to-date, according to Forbes — among the strongest gains in the S&P 500 this year. Other tallies put the 2026 advance closer to 490%, reflecting the stock's volatility. SanDisk has traded independently only since February 24, 2025, when it was spun out of Western Digital at a debut price near $52. It reached a 52-week intraday high around $2,354 on June 22 before falling more than 30%.

Micron closed at $877.57 on August 7, 2026, down from a record close of $1,213.37 on June 25. Over the trailing 12 months the stock is up about 609%. Shares sold off in July as investors reassessed valuations across AI-hardware names.

The gains reflect an unusually tight memory market. AI servers consume large volumes of high-bandwidth DRAM, Micron's specialty, and enterprise NAND flash SSDs, where SanDisk competes; supply discipline has sustained some of the strongest pricing in years.

Both stocks remain well off their summer peaks, and figures move daily; percentage gains cited are year-to-date as of the dates noted.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleForbes· August 1, 2026
    SanDisk Stock Is Still Up 574%. Here’s Where It’s Heading Next In 2026
  2. [2]News articleThe Motley Fool· July 7, 2026
    Sandisk Stock Is Up Nearly 635% in 2026. Can It Still Go Higher?
  3. [3]News articleMacrotrends· August 7, 2026
    Micron Technology — 15-Year Stock Price History
  4. [4]News articleStockAnalysis· August 7, 2026
    Sandisk (SNDK) Stock Price & Overview
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com